{
  "casebody": {
    "data": "<casebody firstpage=\"885\" lastpage=\"885\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties data-order=\"0\" data-type=\"parties\" id=\"b913-6\">ASTRAZENECA LP, Aktiebolaget Draco, KBI Inc., and KBI-E Inc., Plaintiffs-Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellee.</parties>\n<docketnumber data-order=\"1\" data-type=\"docketnumber\" id=\"b913-9\">No. 2011-1506.</docketnumber>\n<court data-order=\"2\" data-type=\"court\" id=\"b913-10\">United States Court of Appeals, Federal Circuit.</court>\n<decisiondate data-order=\"3\" data-type=\"decisiondate\" id=\"b913-11\">April 9, 2012.</decisiondate>\n<attorneys data-order=\"4\" data-type=\"attorneys\" id=\"b913-13\">George F. Pappas, Covington &amp; Burling LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were Jeffrey B. Elikan and Michelle L. Morin.</attorneys>\n<attorneys data-order=\"5\" data-type=\"attorneys\" id=\"b913-14\">Nicole W. Stafford, Wilson Sonsini Goodrich &amp; Rosati, of Austin, TX, argued for defendant-appellee. With her on the brief were Robert Delafield; David S. Steuer and Matthew A. Argenti, of Palo Alto, CA.</attorneys>\n<p data-order=\"6\" data-type=\"legal\" id=\"b913-15\">RADER, Chief Judge, PLAGER and LOURIE, Circuit Judges.</p>\n<opinion data-order=\"7\" data-type=\"opinion\" id=\"x999-1\" type=\"majority\">\n<p id=\"b913-16\">JUDGMENT</p>\n<author id=\"b913-17\">PER CURIAM.</author>\n<p id=\"b913-18\">This Cause having been heard and considered, it is</p>\n<p id=\"b913-19\">Ordered and Adjudged:</p>\n<p id=\"b913-20\">AFFIRMED. <em>See </em>Fed. Cir. R. 36.</p>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}